MarkosWebWeb intelligence for the agentic economy

株式会社Epigeneron

Site unreachable

Epigeneron Inc. is a Drug discovery and detection of gene mutation Company.

epigeneron.comAI readiness report

What it does

"Epigeneron Inc. is a pioneering Insurtech company focused on drug discovery and gene mutation detection. Leveraging cutting-edge genomic technologies, Epigeneron is dedicated to developing therapeutic solutions for challenging diseases such as cancer and neurological disorders. Their proprietary gene locus-specific ChIP method enables the identification of drug targets, leading to the creation of innovative treatments for patients in need. Additionally, Epigeneron's ORNi-PCR® technology accelerates gene mutation detection and enhances the precision of next-generation sequencing (NGS) analysis. This advancement not only improves the accuracy of genetic diagnostics but also boosts productivity in research institutions. Epigeneron's commitment to advancing precision medicine and genetic research underscores their significant contribution to the healthcare industry."

Next to it in Healthcare and bio · Drug discovery and genomic analysis

  • 株式会社キュライオPlug and Play

    Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy.

  • インタープロテイン株式会社Plug and Play

    Interprotein provides highly active modulators for protein-protein interaction (PPI) targets.

  • Metagen TherapeuticsPlug and Play

    Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.

  • モジュラス株式会社Plug and Play

    Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.

  • OmniSciencePlug and Play

    OmniScience is a leading AI organization advancing life science missions through unparalleled expertise in biology and data science.

  • Notable LabsY Combinator W15

    Personalized drug discovery for blood cancer.

  • SyntheXSOSV SOSV IndieBio 03

    Drugging the undruggable

  • Civetbio500 Global

    Provider of biotechnology service intended to accelerate drug discovery for live bio-therapeutics. The company's service includes a microbiota bank, a clinical intervention platform, and core big data technology that powers their bioinformatics pipeline, enabling researchers to characterize the Asian gut microbiome and understand the varying profiles across country regions.